Creative Medical Technology Holdings Inc (CELZ)

[Starbeck]

History DD Stock Pile for $CELZ HERE

But first, a quick comment about the PR laments...PR? How about a 1HR State-Owned Russian press conference about CaverStem being discussed by the Minister of Urology and Dr. Gershman? Doesn't that qualify as a PR "coming in a few days"? They said on the PR OCT 17th: "A press release will be issued in the days following October 19th to provide further details, including the observations of the physicians involved." Isn't that what that press conference was? A panel of physicians discussing their observations about the treatment of patients with CaverStem? Sheesh. I'll take international media exposure over an 8K or PR update anytime.

Now back to the topic at hand...for when you get twitchy...just refresh yourself with some CELZ facts:

What about this CMTH Mgmt team and their experience running biotech companies to commercialization or successful acquisition?? Thick as mud they is.....MediStem was founded in 2005. LOOK at who founded it. It traded at pathetic PPS levels and didn't hit 60 cents until 2012. By 2013, it was trading at 86 cents. It hit 60 cents after 7 years of itching and scratching. CELZ, the commercializing unit of CMTH, was formed in 2011. 7 years ago. 7 YEARS AGO!!!!!!!!!!!!!!!!!!! Is there a repeat coming?

To be clear, MediStem and CELZ are NOT pureplays for one another on a vis-a-vis basis so we can't say that what happened to Medistem will happen exactly the same for CELZ. IMO, CELZ has a TON more going for it, revenues included.The narrative is similar and the people are the same (minus the CEO but he was "around" that team) and the industry is close enough. Plus, when MediStem sold out, their market cap was $12.3 million. CELZ's market cap TODAY is ~ $12.5M and it isn't even getting ginned up yet. Clearly CELZ has a different share structure and a whole lot more potential for immediate revenue compared to Medistem which sold out on a non-commercialized basis. This is all why I feel very optimistic about this CMTH team.

What about the history of CELZ?

Brief Summary:

Creative Medical Technology Holdings, Inc., through its subsidiaries, engages in the stem cell research and developing applications to treat male sexual dysfunction and related issues. The company markets its erectile dysfunction (ED) treatment under the Caverstem name to physicians for use with their patients suffering from ED. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona. Creative Medical Technology Holdings, Inc. is a subsidiary of Creative Medical Health, Inc.

You also need to look at the connection of Dr. Amit N. Patel and Ichim. And then the three amigos Tim Warbington (CELZ CEO) plus those two:
Creative Medical Technology Holdings, Inc. is a publicly traded commercial stage biotechnology company which was spun out from Creative Medical Health, Inc. a privately held biotechnology incubator and holding company formed by Mr. Warbington, Dr. Amit Patel and Dr. Thomas Ichim in 2011.

Creative Medical Technology Holdings (CMTH) Scientific Advisory Board

Dr. Thomas Ichim MD - Dr. Ichim has been responsible for 3 FDA cleared Investigational New Drug (IND) Applications in the area of cellular therapy and is inventor of over 100 patents and patent applications.

Santosh Kesari MD, Ph.D, FANA, FAAN - Chair and Professor, Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, as well as Director of Neuro-Oncology, Providence Saint John's Health Center, who leads the Pacific Neuroscience Research Center at Pacific Neuroscience Institute

Alexander Gershman MD - Dr. Alexander Gershman, member of the Company's Scientific Advisory Board and Director of Institute of Advanced Urology at the Cedars-Sinai Medical Tower; Director of Urologic Laparoscopy in the Division of Urology, Harbor-UCLA Medical Center."

MediStem went to ~$2.50 PPS before it sold for ~ $1.40 I believe. Some people I have chatted with said that it went from .02 to .75 in a flash before going even higher. You need to look at the names above (CMTH advisors) and then read these links care-fully. Notice any similarities? Rest easy folks...it's coming!

Read 1st: https://www.cellmedicine.com/medistem-inc-annual-letter-to-shareholders/

Read 2nd: https://www.prnewswire.com/news-releases/intrexon-completes-acquisition-of-medistem-248984811.html

Read 3rd: http://www.marketwired.com/press-release/urologic-surgery-pioneer-dr-alexander-gershman-joins-medistems-scientific-advisory-board-pinksheets-meds-1728155.htm

READ 4TH (THIS IS CRITICAL TO THE NARRATIVE OF OUR FOCUS ON CELZ IN THE OTC BIN): https://www.equities.com/news/score-one-for-the-microcaps-intrexon-to-acquire-medistem-for-26-million

CELZ Bonus item for those that haven't seen:

https://www.slideshare.net/DonaldDickerson/caverstem-corporate-presentation

What is the bottom line with all this? The key here is this part of the team. Dr. Thomas Ichim is THE dude that made MediStem viable scientifically speaking. Do some DD on him. And then do the same on Dr. Santosh Kesari. Neither will disappoint!

All posts my opinions, NOT investment advice. I make no warranties on the accuracy of information provided herein or any links herewith. Do your own due diligence and DO NOT BUY if you don't like what you find.